Message From the CEO

Message from CEO We are a global biopharmaceutical company with a steadfast commitment to developing innovative medicines in the fields of neuroscience and oncology.

At the center of our drug development process is a keen focus on how new medicines can be designed to meet the real-world needs of patients, physicians and payers. We ask the important questions upfront about how a new medicine can be best designed, how outcomes can be improved, and how there can be a strong medical, as well as health economics, rationale for a new drug product. We believe that when drug development begins with real world and human questions like these, it can lead to innovative products that can truly help patients and physicians better manage diseases.

Our patient-inspired approach to drug development has led us to create a pipeline of proprietary drug candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Advancing new treatments is a vital endeavor for millions of patients and their families, for the multitude of dedicated healthcare providers, and for the potential impact on our communities. While these novel product candidates in our pipeline have the potential to fuel our future growth, we have a strong financial foundation from our diversified marketed product portfolio that represents our scientific expertise and our proprietary technologies.

In addition to our research and development efforts, we also continue to develop and strengthen our commercial capabilities and infrastructure and our sophisticated manufacturing capabilities. All of which are made possible by the experienced and dedicated team of people who come to work every day with the goal of doing their part to address the difficult-to-treat diseases that we are focused on. Alkermes employees are united in our Purpose to pursue Great Science with Deep Compassion to make a Real Impact in the lives of patients, families, and communities. Together, we have created an organization where all voices are respected and valued, and an environment that fosters equality and compassion.

We couldn’t be more enthusiastic and optimistic about the future growth of Alkermes and we welcome your interest in our company.


Richard F. Pops, Chief Executive Officer